Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. Revenue 2011–2025
Sonoma Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Sonoma Pharmaceuticals Inc. revenue for the quarter ending December 31, 2025 was 4.3 M, a 22.03% increase year-over-year.
- Sonoma Pharmaceuticals Inc. revenue for the twelve months ending December 31, 2025 was 17.5 M, a 36.55% increase year-over-year.
- Sonoma Pharmaceuticals Inc. annual revenue for 2025 was 14.3 M, a 12.19% increase from 2024.
- Sonoma Pharmaceuticals Inc. annual revenue for 2024 was 12.7 M, a 4.05% decrease from 2023.
- Sonoma Pharmaceuticals Inc. annual revenue for 2023 was 13.3 M, a 5.10% increase from 2022.
- Sonoma Pharmaceuticals Inc. annual revenue for 2022 was 12.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sonoma Pharmaceuticals Inc. Revenue — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) revenue over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Sonoma Pharmaceuticals Inc.'s revenue?
Sonoma Pharmaceuticals Inc. (SNOA) reported revenue of $14M for fiscal 2025.
Where can I see SNOA's revenue history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s revenue by year and by quarter, including the growth rate.